- In October 2023, a study published in the BMJ Journal of Neurointerventional Surgery revealed that PreSize, an AI software, outperformed human clinicians in predicting the placement of stents in patients' brains. This advancement highlights the potential of AI integration to create growth opportunities for companies in the neurointerventional market
- In July 2023, MicroVention, Inc., a subsidiary of Terumo Corporation, released the WEB-IT five-year follow-up data and introduced two new sizes to its WEB Aneurysm Embolization System. With seven Good Clinical Practice (GCP) studies and over 200 peer-reviewed publications, the WEB system is now the most extensively studied intrasaccular device available
- In May 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., a medical device company specializing in neurointerventional products for intracranial aneurysms. This acquisition aims to enhance Stryker’s product portfolio for aneurysm treatment solutions
- In June 2022, the Indian subsidiary of Medtronic plc launched the Pipeline Vantage Embolization Device in India, a cutting-edge solution for the treatment of brain aneurysms
- In October 2021, Evasc Neurovascular introduced the third generation of its eCLIPs Bifurcation Flow Diverter, featuring a shapeable delivery wire, smaller size compatible with 0.021” and 0.027” ID microcatheters, and electrolytic detachment, making it more effective for treating intracranial bifurcation aneurysms
